Prenetics Global Limited (PRENW) Stock Price & Analysis
Prenetics Global Limited (PRENW) — price $0.0052 (-8.77%), as of the Nov 19, 2026 trading session.
Educational signal · not a buy or sell recommendation · How to read this
Prenetics Global Limited · PRENW
Prenetics Global Limited is an investment holding company specializing in diagnostics and genetic testing, offering solutions like CircleDNA, Circle HealthPod, and ColoClear. The company focuses on preventative healthcare and early disease detection, operating primarily from its headquarters in Hong Kong.
Price as of Nov 19, 2026
Key Statistics
Not scored: this is a debt/preferred or other non-common instrument, or its reported market value does not match its share basis.
Price & valuation
| Measure | Value |
|---|---|
| Latest provided price | $0.0052 |
| Change on the day | -8.77% |
| 52-week range | $0.0052 – $0.03 |
| Shares traded on the day | 16.9K |
Price & events
Other perspectives
Council score for Prenetics Global (PRENW): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Legends Council
6 lenses, 0 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Sep 3, 2026 · older than the 27 hours refresh window; not a current reading
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: May 2, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On May 2, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.
Readings on this page are from Nov 20, 2026, except a card that shows its own read date.
What is Prenetics Global (PRENW), and what does it report?
Short answer · as of
A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. Prenetics Global Limited (PRENW) is the company analyzed here. It employs 98 people and is led by Sheng Wu Yeung. In Q2 FY2026 it reported revenue of $46M and net income of -$9M.
What do the latest results show for Prenetics Global (PRENW)?
Short answer · as of
The most recent reported quarter, Q2 FY2026, carried revenue of $46M. Against analyst estimates the company has EPS beat 3 of the last 8 reports.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q2 FY2026 | $46M | -$9M | -$0.52 (diluted) |
| Q1 FY2026 | $36M | -$23M | -$1.36 (diluted) |
| Q4 FY2025 | $37M | -$28M | -$1.75 (diluted) |
| Q3 FY2025 | $24M | -$7M | -$0.53 (diluted) |
What are the financial strengths and risks for Prenetics Global (PRENW)?
Short answer · as of
The distress and quality screens read Altman Z 3.77 · Piotroski F 4. Trailing ratios: ROE -49.2% · ROA -44.0% · current ratio 4.04 · earnings yield -23.5% · free-cash-flow yield -12.1%.
Data-derived red flags
- Negative return on equity (-49.2%) — the business is not currently generating profit on shareholder capital.
- Inconsistent delivery — missed Wall Street EPS estimates in 4 of the last 8 reported quarters.
The records behind this page
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held PRENW in their latest 13F filing, and what they did against the filing before it.
None of the 16 tracked investors reported PRENW in their latest 13F filing.
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
Common Questions About PRENW
These answers are editorial: 1 of these 1 answer is drawn from the PRENW research dossier (written Jun 15, 2026 by gemini-2.5-flash). Figures in this section are not part of the source register.
What is Prenetics Global Limited's strategy for growth in the preventative healthcare market?
Prenetics Global Limited's growth strategy in the preventative healthcare market is centered on its diverse portfolio of accessible diagnostic and genetic testing solutions.
Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 15, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 13 figures on this page — 7 from Financial Modeling Prep (FMP) and 6 with no recorded source. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com